Making the discoveries that defeat cancer

  • Home »
  • Research »
  • Repository

  • Administrators Login

  • Repository Homepage
  • About the Repository
  • Browse the Repository
  • Search the Repository
  • Contribute an Article
  • Missing Publications
  • Repository Help

Aurora kinase inhibition downregulates NF-kappa B and sensitises tumour cells to chemotherapeutic agents

Tools
- Tools
+ Tools

Sun, C. B., Chan, F., Briassouli, P., Linardopoulos, S. (2007) Aurora kinase inhibition downregulates NF-kappa B and sensitises tumour cells to chemotherapeutic agents. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 352 (1). pp. 220-225. ISSN 0006-291X

Full text not available from this repository.

Abstract

We have identified that Aurora-A activates NF-kappaB via IkappaBalpha phosphorylation. Here, we analysed different human tumour cell types for their NF-kappaB activity. We found that there is an association between cell resistance to chemotherapeutic agents and NF-kappaB activation. A549 human lung adenocarcinoma cells and SKOV3 human ovarian cancer cells have high levels of NF-kappaB and are resistant to cytotoxic agents such as adriamycin and VP-16 (etoposide). We also found that in A549 and SKOV3 cells treated with a small molecule inhibitor towards Aurora kinases, the NF-kappaB activity was downregulated and the efficacy of cytotoxic drugs was enhanced. In addition, the transcriptional targets Bcl-XL and Bcl-2 were downregulated. This study provides evidence for a potential mechanism of chemoresistance and may be useful for the enhancement of certain chemotherapeutics regimens.

Item Type: Article
Authors (ICR Faculty only): Linardopoulos, Spiros
All Authors: Sun, C. B., Chan, F., Briassouli, P., Linardopoulos, S.
Uncontrolled Keywords: Aurora; NF-kappa B; chemotherapeutic agents Susceptibility gene; drosophila aurora; drug-resistance; protein-kinase; cancer; activation; apoptosis; mechanism; cisplatin; family
Research teams: ICR divisions > Breast Cancer Research > Drug Target Discovery
ICR divisions > Cancer Therapeutics > Drug Target Discovery

ICR divisions > Breast Cancer Research > Target Discovery & Apoptosis
ICR divisions > Cancer Therapeutics > Target Discovery & Apoptosis
Date Deposited: 10 Aug 2007 20:59
Last Modified: 10 Feb 2010 11:48
URI: http://publications.icr.ac.uk/id/eprint/3124

Actions (login required)

View Item View Item
The Royal Marsden - NHS foundation trust